DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Genome-Wide DNA Methylation Study Reveals Specific Signatures in the Affected Arterial Tissue of Patients With Giant Cell Arteritis
This research is part of the doctoral degree awarded to Gonzalo Borrego-Yaniz, MSc, within the Biomedicine program from the University of Granada., [Objective] Giant cell arteritis (GCA) is a large-vessel vasculitis, potentially causing complications such as blindness and strokes. This study aims to gain insights into the pathogenesis of GCA by identifying specific DNA methylation signatures in the arterial tissue of patients with this vasculitis., [Methods] DNA methylation profiling was analyzed in 79 temporal artery biopsy samples (69 patients with GCA and 10 controls) by performing an epigenome-wide association study (EWAS). Differential analysis was performed to identify differentially methylated positions (DMPs) and differentially methylated regions (DMRs). Lastly, we compared our findings with previous transcriptomics and epigenomics studies on GCA-affected arteries., [Results] EWAS identified 3,644 DMPs (Padj < 0.05, |Δβ| > 0.3), indicating a profound alteration within GCA-affected arterial tissue. These DMPs were annotated to 1,517 potentially dysregulated genes. A total of 282 additional genes were identified by annotation of significant DMRs. Pathway enrichment analysis revealed a significant alteration of inflammatory mechanisms, such as interleukin-2 and interleukin-7, as well as pathways related to vascular remodeling. Omics study comparison revealed 37 genes consistently affected across datasets, many of them linked to immune signaling and T cell regulation. Notably, markers of exhausted T cells, including SLAMF6 and HAVCR2, were present among them., [Conclusion] Our study identified GCA-specific DNA methylation signatures in arterial tissue, revealing disrupted inflammatory and vascular pathways and suggesting the involvement of exhausted T cells in this condition. These findings offer new insights into GCA pathogenesis and provide new potential targets for the treatment of this debilitating disease., Supported by a research grant from FOREUM Foundation for Research in Rheumatology. Dr Borrego-Yaniz's contract is part of the grant PREP2022-000712, funded by the MCIN/AEI/10.13039/501100011033 and the ESF+. Dr Ortiz-Fernández's work is supported by a Ramon y Cajal fellowship (RYC2022-036635-I) funded by MICIU/AEI/10.13039/501100011033 and by ESF+. Drs Martin, Croci, and Ortiz-Fernández contributed equally to this work., Peer reviewed
Project:
AEI RYC2022-036635-I
,
AEI PREP2022-000712
DOI: http://hdl.handle.net/10261/423964, https://api.elsevier.com/content/abstract/scopus_id/105027221005
HANDLE: http://hdl.handle.net/10261/423964, https://api.elsevier.com/content/abstract/scopus_id/105027221005